ID   RTN4R_RAT               Reviewed;         473 AA.
AC   Q99M75;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   02-OCT-2024, entry version 174.
DE   RecName: Full=Reticulon-4 receptor;
DE   AltName: Full=Nogo receptor;
DE            Short=NgR;
DE   AltName: Full=Nogo-66 receptor;
DE   Flags: Precursor;
GN   Name=Rtn4r; Synonyms=Nogor;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Jin W.-L., Jia W., Long M., Ju G.;
RT   "Identification and preparation of polyclonal antibody against rat Nogo
RT   receptor.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Oertle T., van der Haar M.E., Bandtlow C.E., Huber A.B., Simonen M.,
RA   Schnell L., Broesamle C., Schwab M.E.;
RT   "Nogo-A: a molecule with two active sites and two membrane topologies.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   REVIEW.
RX   PubMed=11891768; DOI=10.1002/jnr.10134;
RA   Ng C.E.L., Tang B.L.;
RT   "Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron
RT   regeneration.";
RL   J. Neurosci. Res. 67:559-565(2002).
RN   [4]
RP   INTERACTION WITH NGFR, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12426574; DOI=10.1038/nn975;
RA   Wong S.T., Henley J.R., Kanning K.C., Huang K.H., Bothwell M., Poo M.M.;
RT   "A p75(NTR) and Nogo receptor complex mediates repulsive signaling by
RT   myelin-associated glycoprotein.";
RL   Nat. Neurosci. 5:1302-1308(2002).
RN   [5]
RP   FUNCTION.
RX   PubMed=12037567; DOI=10.1038/417547a;
RA   GrandPre T., Li S., Strittmatter S.M.;
RT   "Nogo-66 receptor antagonist peptide promotes axonal regeneration.";
RL   Nature 417:547-551(2002).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH MAG; RTN4 AND OMG, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15673660; DOI=10.1523/jneurosci.4464-04.2005;
RA   Venkatesh K., Chivatakarn O., Lee H., Joshi P.S., Kantor D.B., Newman B.A.,
RA   Mage R., Rader C., Giger R.J.;
RT   "The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor
RT   selective for myelin-associated glycoprotein.";
RL   J. Neurosci. 25:808-822(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=18411262; DOI=10.1074/jbc.m802067200;
RA   Williams G., Wood A., Williams E.J., Gao Y., Mercado M.L., Katz A.,
RA   Joseph-McCarthy D., Bates B., Ling H.P., Aulabaugh A., Zaccardi J., Xie Y.,
RA   Pangalos M.N., Walsh F.S., Doherty P.;
RT   "Ganglioside inhibition of neurite outgrowth requires Nogo receptor
RT   function: identification of interaction sites and development of novel
RT   antagonists.";
RL   J. Biol. Chem. 283:16641-16652(2008).
RN   [8]
RP   INTERACTION WITH MAG; RTN4 AND OMG, GLYCOSYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19420245; DOI=10.1523/jneurosci.4935-08.2009;
RA   Robak L.A., Venkatesh K., Lee H., Raiker S.J., Duan Y., Lee-Osbourne J.,
RA   Hofer T., Mage R.G., Rader C., Giger R.J.;
RT   "Molecular basis of the interactions of the Nogo-66 receptor and its
RT   homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-
RT   Fc, a novel antagonist of CNS myelin inhibition.";
RL   J. Neurosci. 29:5768-5783(2009).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22325200; DOI=10.1016/j.neuron.2011.11.029;
RA   Wills Z.P., Mandel-Brehm C., Mardinly A.R., McCord A.E., Giger R.J.,
RA   Greenberg M.E.;
RT   "The Nogo receptor family restricts synapse number in the developing
RT   hippocampus.";
RL   Neuron 73:466-481(2012).
RN   [10]
RP   FUNCTION.
RX   PubMed=26335717; DOI=10.1038/cddis.2015.228;
RA   Palandri A., Salvador V.R., Wojnacki J., Vivinetto A.L., Schnaar R.L.,
RA   Lopez P.H.;
RT   "Myelin-associated glycoprotein modulates apoptosis of motoneurons during
RT   early postnatal development via NgR/p75(NTR) receptor-mediated activation
RT   of RhoA signaling pathways.";
RL   Cell Death Dis. 6:E1876-E1876(2015).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 27-312, AND DISULFIDE BONDS.
RX   PubMed=20815818; DOI=10.1042/ba20100061;
RA   Weinreb P.H., Wen D., Qian F., Wildes C.P., Garber E.A., Walus L.,
RA   Jung M.Y., Wang J., Relton J.K., Amatucci J., Wang R., Porreca F.,
RA   Silvian L., Meier W., Pepinsky R.B., Lee D.H.;
RT   "Resolution of disulfide heterogeneity in Nogo receptor I fusion proteins
RT   by molecular engineering.";
RL   Biotechnol. Appl. Biochem. 57:31-45(2010).
CC   -!- FUNCTION: Receptor for RTN4, OMG and MAG (PubMed:12037567,
CC       PubMed:15673660, PubMed:19420245). Functions as a receptor for the
CC       sialylated gangliosides GT1b and GM1. Besides, functions as a receptor
CC       for chondroitin sulfate proteoglycans. Can also bind heparin.
CC       Intracellular signaling cascades are triggered via the coreceptor NGFR
CC       (By similarity). Signaling mediates activation of Rho and downstream
CC       reorganization of the actin cytoskeleton (PubMed:18411262). Mediates
CC       axonal growth inhibition (PubMed:12037567). May play a role in
CC       regulating axon regeneration and neuronal plasticity in the adult
CC       central nervous system. Plays a role in postnatal brain development.
CC       Required for normal axon migration across the brain midline and normal
CC       formation of the corpus callosum (By similarity). Protects motoneurons
CC       against apoptosis; protection against apoptosis is probably mediated
CC       via interaction with MAG (PubMed:26335717). Acts in conjunction with
CC       RTN4 and LINGO1 in regulating neuronal precursor cell motility during
CC       cortical development. Like other family members, plays a role in
CC       restricting the number dendritic spines and the number of synapses that
CC       are formed during brain development (PubMed:22325200).
CC       {ECO:0000250|UniProtKB:Q99PI8, ECO:0000250|UniProtKB:Q9BZR6,
CC       ECO:0000269|PubMed:12037567, ECO:0000269|PubMed:15673660,
CC       ECO:0000269|PubMed:18411262, ECO:0000269|PubMed:22325200,
CC       ECO:0000269|PubMed:26335717}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with MAG
CC       (PubMed:15673660, PubMed:19420245). Interacts with RTN4 and OMG
CC       (PubMed:15673660, PubMed:19420245). Interacts with LINGO1 and NGFR (By
CC       similarity). Interacts with KIAA0319L (By similarity). Interacts with
CC       OLFM1; this inhibits interaction with LINGO1 and NGFR (By similarity).
CC       {ECO:0000250|UniProtKB:Q99PI8, ECO:0000250|UniProtKB:Q9BZR6,
CC       ECO:0000269|PubMed:15673660, ECO:0000269|PubMed:19420245}.
CC   -!- INTERACTION:
CC       Q99M75; Q96FE5: LINGO1; Xeno; NbExp=2; IntAct=EBI-7370412, EBI-719955;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15673660,
CC       ECO:0000269|PubMed:19420245, ECO:0000269|PubMed:22325200}; Lipid-
CC       anchor, GPI-anchor {ECO:0000250|UniProtKB:Q99PI8}. Membrane raft
CC       {ECO:0000269|PubMed:15673660}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q99PI8}. Perikaryon
CC       {ECO:0000269|PubMed:15673660}. Cell projection, axon
CC       {ECO:0000269|PubMed:12426574}. Note=Detected along dendrites and axons,
CC       close to synapses, but clearly excluded from synapses.
CC       {ECO:0000250|UniProtKB:Q99PI8}.
CC   -!- TISSUE SPECIFICITY: Detected in embryonic cerebellum, in spinal cord
CC       motor neurons and in dorsal root ganglia (PubMed:12426574). Detected in
CC       adult brain, in neocortex, hippocampus, striatum, thalamus and dorsal
CC       root ganglion neurons (at protein level).
CC       {ECO:0000269|PubMed:15673660}.
CC   -!- DEVELOPMENTAL STAGE: Expression is high in adult, but very low in
CC       neonate dorsal root ganglion neurons (at protein level).
CC       {ECO:0000269|PubMed:15673660}.
CC   -!- PTM: N-glycosylated. O-glycosylated. Contains terminal sialic acid
CC       groups on its glycan chains. {ECO:0000269|PubMed:19420245}.
CC   -!- SIMILARITY: Belongs to the Nogo receptor family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Nerve regrowth: nipped by a
CC       no-go - Issue 69 of April 2006;
CC       URL="https://web.expasy.org/spotlight/back_issues/069";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY028438; AAK20166.1; -; mRNA.
DR   EMBL; AF462390; AAM46772.1; -; mRNA.
DR   RefSeq; NP_446065.1; NM_053613.1.
DR   PDB; 3KJ4; X-ray; 3.10 A; A/D=27-312.
DR   PDBsum; 3KJ4; -.
DR   AlphaFoldDB; Q99M75; -.
DR   SMR; Q99M75; -.
DR   BioGRID; 250215; 5.
DR   IntAct; Q99M75; 1.
DR   MINT; Q99M75; -.
DR   STRING; 10116.ENSRNOP00000041517; -.
DR   GlyCosmos; Q99M75; 2 sites, No reported glycans.
DR   GlyGen; Q99M75; 2 sites.
DR   iPTMnet; Q99M75; -.
DR   PhosphoSitePlus; Q99M75; -.
DR   PaxDb; 10116-ENSRNOP00000041517; -.
DR   ABCD; Q99M75; 2 sequenced antibodies.
DR   Ensembl; ENSRNOT00000051037.6; ENSRNOP00000041517.5; ENSRNOG00000030920.6.
DR   Ensembl; ENSRNOT00055005627; ENSRNOP00055004208; ENSRNOG00055003604.
DR   Ensembl; ENSRNOT00060021733; ENSRNOP00060017200; ENSRNOG00060012784.
DR   Ensembl; ENSRNOT00065013282; ENSRNOP00065009833; ENSRNOG00065008377.
DR   GeneID; 113912; -.
DR   KEGG; rno:113912; -.
DR   AGR; RGD:620810; -.
DR   CTD; 65078; -.
DR   RGD; 620810; Rtn4r.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000160711; -.
DR   HOGENOM; CLU_000288_18_6_1; -.
DR   InParanoid; Q99M75; -.
DR   OMA; HPHAFHD; -.
DR   OrthoDB; 5394956at2759; -.
DR   PhylomeDB; Q99M75; -.
DR   TreeFam; TF330080; -.
DR   EvolutionaryTrace; Q99M75; -.
DR   PRO; PR:Q99M75; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000030920; Expressed in frontal cortex and 17 other cell types or tissues.
DR   GO; GO:0044295; C:axonal growth cone; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0043198; C:dendritic shaft; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB.
DR   GO; GO:1905573; F:ganglioside GM1 binding; ISS:UniProtKB.
DR   GO; GO:1905576; F:ganglioside GT1b binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0038131; F:neuregulin receptor activity; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0048495; F:Roundabout binding; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; IMP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0022038; P:corpus callosum development; ISS:UniProtKB.
DR   GO; GO:0050919; P:negative chemotaxis; IBA:GO_Central.
DR   GO; GO:0030517; P:negative regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISS:UniProtKB.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; TAS:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0023041; P:neuronal signal transduction; ISS:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0150052; P:regulation of postsynapse assembly; ISO:RGD.
DR   GO; GO:0051963; P:regulation of synapse assembly; ISO:RGD.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR050541; LRR_TM_domain-containing.
DR   PANTHER; PTHR24369; ANTIGEN BSP, PUTATIVE-RELATED; 1.
DR   PANTHER; PTHR24369:SF174; RETICULON-4 RECEPTOR; 1.
DR   Pfam; PF13855; LRR_8; 2.
DR   SMART; SM00369; LRR_TYP; 8.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Disulfide bond; Glycoprotein;
KW   GPI-anchor; Leucine-rich repeat; Lipoprotein; Membrane; Receptor;
KW   Reference proteome; Repeat; Signal.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..447
FT                   /note="Reticulon-4 receptor"
FT                   /id="PRO_0000022259"
FT   PROPEP          448..473
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000022260"
FT   DOMAIN          27..57
FT                   /note="LRRNT"
FT                   /evidence="ECO:0000255"
FT   REPEAT          56..79
FT                   /note="LRR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          80..103
FT                   /note="LRR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          105..128
FT                   /note="LRR 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          129..152
FT                   /note="LRR 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          153..176
FT                   /note="LRR 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          178..200
FT                   /note="LRR 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          202..224
FT                   /note="LRR 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          225..248
FT                   /note="LRR 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          250..273
FT                   /note="LRR 9"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          260..310
FT                   /note="LRRCT"
FT                   /evidence="ECO:0000255"
FT   REGION          346..446
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..443
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           447
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        27..33
FT                   /evidence="ECO:0000269|PubMed:20815818,
FT                   ECO:0007744|PDB:3KJ4"
FT   DISULFID        31..43
FT                   /evidence="ECO:0000269|PubMed:20815818,
FT                   ECO:0007744|PDB:3KJ4"
FT   DISULFID        264..287
FT                   /evidence="ECO:0000269|PubMed:20815818,
FT                   ECO:0007744|PDB:3KJ4"
FT   DISULFID        266..335
FT                   /evidence="ECO:0000250|UniProtKB:Q99PI8"
FT   DISULFID        309..336
FT                   /evidence="ECO:0000250|UniProtKB:Q99PI8"
FT   CONFLICT        12..13
FT                   /note="LA -> PT (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        43
FT                   /note="C -> R (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        53
FT                   /note="T -> A (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        284
FT                   /note="E -> G (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        287
FT                   /note="C -> S (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        303
FT                   /note="A -> T (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        355
FT                   /note="A -> V (in Ref. 1; AAK20166)"
FT                   /evidence="ECO:0000305"
FT   STRAND          32..34
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          36..38
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          94..96
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   TURN            98..103
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   TURN            123..128
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   TURN            147..152
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   TURN            171..176
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          182..184
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   TURN            195..200
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          206..208
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   TURN            219..224
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   HELIX           268..277
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   HELIX           291..293
FT                   /evidence="ECO:0007829|PDB:3KJ4"
FT   HELIX           298..300
FT                   /evidence="ECO:0007829|PDB:3KJ4"
SQ   SEQUENCE   473 AA;  50851 MW;  3DFD17EA4651FECB CRC64;
     MKRASSGGSR LLAWVLWLQA WRVATPCPGA CVCYNEPKVT TSCPQQGLQA VPTGIPASSQ
     RIFLHGNRIS YVPAASFQSC RNLTILWLHS NALAGIDAAA FTGLTLLEQL DLSDNAQLRV
     VDPTTFRGLG HLHTLHLDRC GLQELGPGLF RGLAALQYLY LQDNNLQALP DNTFRDLGNL
     THLFLHGNRI PSVPEHAFRG LHSLDRLLLH QNHVARVHPH AFRDLGRLMT LYLFANNLSM
     LPAEVLVPLR SLQYLRLNDN PWVCDCRARP LWAWLQKFRG SSSEVPCNLP QRLAGRDLKR
     LAASDLEGCA VASGPFRPFQ TNQLTDEELL GLPKCCQPDA ADKASVLEPG RPASAGNALK
     GRVPPGDTPP GNGSGPRHIN DSPFGTLPGS AEPPLTALRP GGSEPPGLPT TGPRRRPGCS
     RKNRTRSHCR LGQAGSGSSG TGDAEGSGAL PALACSLAPL GLALVLWTVL GPC
//
